Int J Med Sci 2019; 16(7):922-930. doi:10.7150/ijms.34322

Research Paper

The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer

Jiaping Li1*, Xinlu Tao1*, Jing Shen2,3, Linling Liu4, Qijie Zhao2,3, Yongshun Ma2,3, Zheng Tao1, Yan Zhang1, Boying Ding1✉, Zhangang Xiao2,3✉

1. Department of Cardiothoracic Surgery, Yijishan Hospital, Wannan Medical College, Wuhu, 241001, Anhui, PR China
2. Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, PR China
3. South Sichuan Institution for Translational Medicine, Luzhou, 646000, Sichuan, PR China
4. The People's Hospital of Weiyuan, Neijiang, Sichuan, PR China
* These authors contribute equally to this work

Abstract

Background: Lung cancer is one of the most common malignant tumors. Histone methylation was reported to regulate the expression of a variety of genes in cancer. However, comprehensive understanding of the expression profiles of histone methyltransferases and demethylases in lung cancer is still lacking.

Methods: We analyzed the expression profile of methyltransferases and demethylases in non-small cell lung cancer (NSCLC) using TCGA and cBioportal databases. The mutation, expression level, association with survival and clinical parameters of histone methyltransferases and demethylases were determined.

Results: We found overall upregulation of histone regulators in NSCLC. Mutation and copy number alteration of histone methylation related genes both exist in NSCLC. The expression of certain histone methylation related genes were significantly associated with overall survival and clinical attributes.

Conclusions: Our result suggests that alteration of histone methylation is strongly involved in NSCLC. Some histone methylation related genes might serve as potential prognosis predictor or therapeutic target for NSCLC. The significance of some histone methylation related genes was contrary to the literature and awaits further validation.

Keywords: histone methylation, lung cancer, methyltransferases, demethylases, mutation, survival

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Li J, Tao X, Shen J, Liu L, Zhao Q, Ma Y, Tao Z, Zhang Y, Ding B, Xiao Z. The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer. Int J Med Sci 2019; 16(7):922-930. doi:10.7150/ijms.34322. Available from http://www.medsci.org/v16p0922.htm